Cadrenal Therapeutics, Inc. Common Stock
Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patien…
Biotechnology
US, Ponte Vedra [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Cadrenal Therapeutics, Inc. Common Stock (CVKD) to it's peer group.
Peer Group
GPCR MNPR FHTX IKNA ENOB ZIVO PMVP ELYM MLYS HCWB NVCT ANEB SNTI SABS QNRX IKT ANTX MIRO XCUR
Compare Together
Loading...